<DOC>
	<DOCNO>NCT01334853</DOCNO>
	<brief_summary>The rationale conduct study explore potential clinical peripheral biomarkers subject require daily medium high dose inhale corticosteroid persistent asthma</brief_summary>
	<brief_title>A Study Assess Selected Biomarkers Subjects Requiring Daily Inhaled Corticosteroids Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Age 18 75 time screen Written informed consent locally require authorization obtain subject prior performing protocolrelated procedure , include screen evaluation History physiciandiagnosed asthma least 12 month prior screen Stable Medium highdose ICS divide twice daily outline NHLBI Asthma Guidelines , 2007 Any medical condition , opinion investigator medical monitor , would interfere interpretation subject safety study result Concurrent enrollment another clinical study Use immunosuppressive medication within 3 month prior screen Acute upper low respiratory infection require antibiotic antiviral medication 30 day prior screen screning period . Receipt immunoglobulin blood product within 30 day prior screen screen period Receipt investigational nonbiological drug therapy within 30 day 5 halflives prior screen whichever longer ; receipt market investigational biologic within 6 month 5 halflives prior screen whichever longer Pregnant , lactating , breastfeed woman Diagnosis lung disease persistent asthma History smoking â‰¥10 pack year smoke within 12 month prior screen History active , infectious hepatitis A , B , C human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>